SCHEMBL19936196

SCHEMBL19936196

C=CN/C=C(\Cc1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
AKR1B1 P15121 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
MAOA P21397 2/20 0.37
MAOB P27338 2/20 0.37
CTSL P07711 1/20 0.37
KCNH2 Q12809 1/20 0.36
AKT1 P31749 1/20 0.35
EPHX2 P34913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7737076 0.76 CES2 (0.43) CES2CES1AKR1B1MEN1KMT2A
SCHEMBL4823768 0.76 CES2 (0.43) CES2CES1AKR1B1MEN1KMT2A
SCHEMBL18660610 0.75 MAPT (0.36) KMT2AMAOAMAOBAKT1
SCHEMBL6130072 0.74 CES2 (0.44) CES2CES1AKR1B1MEN1KMT2A
SCHEMBL7737204 0.73 CES2 (0.40) CES2CES1AKR1B1MEN1KMT2A
SCHEMBL7737201 0.73 CES2 (0.40) CES2CES1AKR1B1MEN1KMT2A
SCHEMBL2146350 0.72 CES2 (0.43) CES2CES1AKR1B1MAOAMAOB
SCHEMBL29028265 0.72 CES2 (0.43) CES2CES1AKR1B1MEN1KMT2A
SCHEMBL3851045 0.71 CYP3A4 (0.53) CES2CES1AKR1B1
SCHEMBL18616874 0.69 CYP2C9 (0.31) CES2CES1AKR1B1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018045071-A1 INHIBITORS OF CELLULAR METABOLIC PROCESSES AGIOS PHARMACEUTICALS, INC. (US) 2018-03-08 WO disclosed